Cytomics: A multiparametric, dynamic approach to cell research G Herrera, L Diaz, A Martinez-Romero, A Gomes, E Villamón, ... Toxicology in vitro 21 (2), 176-182, 2007 | 65 | 2007 |
Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance C Pallarés, Â Carvalho-Gomes, V Hontangas, I Conde, T Di Maira, ... Journal of Clinical Virology 102, 77-83, 2018 | 41 | 2018 |
Systems Biology and immune aging JE O’Connor, G Herrera, A Martinez-Romero, FS de Oyanguren, L Diaz, ... Immunology Letters 162 (1), 334-345, 2014 | 33 | 2014 |
One‐quarter of chronic hepatitis D patients reach HDV‐RNA decline or undetectability during the natural course of the disease A Palom, S Sopena, M Riveiro‐Barciela, A Carvalho‐Gomes, A Madejón, ... Alimentary pharmacology & therapeutics 54 (4), 462-469, 2021 | 28 | 2021 |
Oxidative imbalance in low/intermediate-1-risk myelodysplastic syndrome patients: The influence of iron overload D Ivars, MT Orero, K Javier, L Díaz-Vico, JL García-Giménez, S Mena, ... Clinical Biochemistry 50 (16-17), 911-917, 2017 | 21 | 2017 |
A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area  Carvalho-Gomes, A Cubells, C Pallarés, V Hontangas, I Conde, ... PLoS One 15 (2), e0228351, 2020 | 17 | 2020 |
Real‐time cytometric assay of nitric oxide and superoxide interaction in peripheral blood monocytes: A no‐wash, no‐lyse kinetic method S Balaguer, L Diaz, A Gomes, G Herrera, JE O'Connor, A Urios, V Felipo, ... Cytometry Part B: Clinical Cytometry 92 (3), 211-217, 2017 | 14 | 2017 |
Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk–an observational, retrospective study V Aguilera, T Di Maira, I Conde, V Fornés‐Ferrer, C Vinaixa, C Pallarés, ... Transplant International 31 (6), 649-657, 2018 | 12 | 2018 |
Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease AL Simão, CS Palma, L Izquierdo-Sanchez, A Putignano, ... JHEP Reports 5 (5), 100697, 2023 | 11 | 2023 |
Overview of cellular and soluble mediators in systemic inflammation associated with non-alcoholic fatty liver disease P Marques, V Francisco, L Martínez-Arenas, Â Carvalho-Gomes, ... International Journal of Molecular Sciences 24 (3), 2313, 2023 | 9 | 2023 |
Cytomegalovirus specific polyfunctional T-cell responses expressing CD107a predict control of CMV infection after liver transplantation A Carvalho-Gomes, A Cubells, C Pallares, F Corpas-Burgos, ... Cellular Immunology 371, 104455, 2022 | 5 | 2022 |
Pilot validation study of a rapid test in oral fluid for population screening of hepatitis C virus infection C Pallarés, AS Carvalho-Gomes, I Conde, T Di Maira, V Hontangas, ... Journal of Hepatology 1 (66), S403-S404, 2017 | 2 | 2017 |
Cytomegalovirus specific polyfunctional T-cells control CMV reactivation after liver transplantation  Carvalho-Gomes, A Cubells, C Pallarés, E Nunez, M Berenguer, ... Transplantation 105 (8), 76-77, 2021 | 1 | 2021 |
Development Of An Oxidative Cytomic Panel Of High-Content Miniaturized Assays for Detection of In Vitro Cytotoxicity and Prediction of Acute Toxicity of Drugs and Xenobiotics ÂS Carvalho Gomes Development Of An Oxidative Cytomic Panel Of High-Content Miniaturized …, 2016 | 1 | 2016 |
Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors R Martin-Mateos, L Martínez-Arenas, Á Carvalho-Gomes, L Aceituno, ... Journal of Hepatology, 2024 | | 2024 |
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant G Mehta, A Riva, MP Ballester, E Uson, M Pujadas, Â Carvalho-Gomes, ... Hepatology communications 7 (11), e0273, 2023 | | 2023 |
Overcoming barriers to care for Delta infected patients A Bono, Â Carvalho-Gomes, MDG Ruiz, SS Vidal, J Carlos, R Díaz, ... Journal of Hepatology 78, S1124, 2023 | | 2023 |
In patients with chronic hepatitis D, the declineof≥ 2 log HDV-RNA levels that remain detectable is associated with better clinical outcomes A Palom, S Rodriguez-Tajes, A Bono, A Madejón, M Riveiro-Barciela, ... Group 100, 23, 2023 | | 2023 |
External validation of models to predict hepatocellular carcinoma (HCC) in HCV SVR F3-F4 patients I Sahuco, Â Carvalho-Gomes, T Valcheva, E Vidal, L Martínez-Arenas, ... Journal of Hepatology 78, S1172, 2023 | | 2023 |
SIMPLE SCORE TO ASSESS CARDIOVASCULAR RISK POST-LIVER TRANSPLANTATION T Di Maira, A Bosca-Robledo, S Martinez-Delgado, A Carvalho-Gomes, ... HEPATOLOGY 76, S530-S530, 2022 | | 2022 |